Canada Markets close in 4 hrs 3 mins

Mindset Pharma Inc. (MSSTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3315+0.0215 (+6.94%)
As of 11:21AM EDT. Market open.

Mindset Pharma Inc.

217 Queen Street West
Suite 401
Toronto, ON M5V 0R2
Canada

https://www.mindsetpharma.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. James Andre-Charles LanthierChief Exec. Officer184.03kN/A1975
Mr. Arvin Ramos CPAChief Financial Officer65.26kN/A1979
Mr. Joseph AraujoChief Scientific Officer, Member of Scientific Advisory Board & Director19.19kN/A1977
Mr. Jason AtkinsonVP of Corp. Devel.115.16kN/AN/A
Dr. Abdelmalik Slassi Ph.D.Sr. VP of Innovation & Member of Scientific Advisory BoardN/AN/AN/A
Dr. Fiona Randall B.Sc., Ph.D.Sr. VP of External Alliances & Scientific StrategyN/AN/AN/A
Chris IrwinCorp. Sec.N/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Mindset Pharma Inc. operates as a neuro-pharmaceutical drug discovery and development platform company. It offers psychedelic compounds for treatment-resistant neurological and psychiatric disorders. The company was founded in 2019 and is based in Toronto, Canada.

Corporate Governance

Mindset Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.